Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-31

Clinical Trial Update: REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center [NA]

View source ↗

Summary

This update describes the REVASC-PAD feasibility study on restricted vascular exercise for peripheral arterial disease at the University of Tennessee Medical Ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Tennessee Graduate School of Medicine | Conditions: Peripheral Arterial Disease | NA | Status: NOT_YET_RECRUITING